NCT06704269 2026-04-06
Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia Gravis
Novartis
Phase 1/2 Recruiting
Clinical Trials
4 trialsNCT06359041 2026-02-20
RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
Cabaletta Bio
Phase 1/2 Active not recruiting
NCT07250750 2026-02-11
Synergy-MG
ImmunAbs Inc.
Phase 1/2 Recruiting
NCT07372807 2026-01-28
RIPERT-MG
Xinqiao Hospital of Chongqing
Phase 1/2 Not yet recruiting